Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Eleven Biotherapeutics raises $35mm through Series A round; later gets another $10mm

Executive Summary

Protein therapeutics start-up Eleven Biotherapeutics has raised $35mm through its Series A financing. Flagship Ventures and Third Rock Ventures, which both helped form the company in 2009 with $1mm in seed funding, co-led the round.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies